|
|
|
Tue 17 Mar 2026
Close: 18 593c 
Day's move: 63c (0.34%)
Volume: 1 123 416
Trades: 6 053
|
|
|
|
Remgro - trading statement
Remgro's results for the six months ended 31 December 2025 (current period) are due to be released on the Stock Exchange News Service (SENS) on or about 25 March 2026.
Remgro's headline earnings per share (HEPS) for the current period is expected to be between 914 cents and 948 cents compared to the HEPS of 672 cents for the reported comparative six months ended 31 December 2024, an expected increase of between 36% and 41%.
|
|
Click here for original article
|
| |
Remgro - disposal of shares held in FirstRand
In continuation of the aforementioned disposal process, Remgro has disposed of 51 966 739 additional FirstRand shares in the market over the period 2 February 2026 to 10 March 2026, at an average price per share of R93.87, for an aggregate consideration of R4 878 million. The proceeds from the disposal adds to Remgro's strategic cash resources, which is managed in accordance with its capital allocation framework.
|
|
Click here for original article
|
| |
Remgro - restructuring interests in Mediclinic
Shareholders were advised that negotiations are ongoing and remain subject to finalisation, and if successfully concluded, the Potential Transaction may have a material effect on the price of Remgro's securities. Accordingly, Shareholders are advised to continue to exercise caution when dealing in Remgro securities until a further detailed announcement is made.
|
|
Click here for original article
|
| |
| |
| Click here for full news archive for this company |
|
| Closing price data source: JSE Ltd. All other statistics calculated by ProfileData. |
| |
|
|
